Antiva Biosciences
PrivateLast Round
Series E
Apr 27, 2023
Total Funding Raised
$139.4M
Momentum Score
25 /100
Company Overview
Antiva Biosciences is a biotechnology company that develops small molecule antivirals aimed at enhancing health outcomes for patients affected by HPV and other viral infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antiva Biosciences Comps
Public and private peers based on sector, stage, and business model.
Antiva Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Apr 27, 2023 | ||||
| Series D | Nov 2, 2021 | ||||
| Series C Extension | Jul 10, 2018 | ||||
| Series C | Mar 28, 2017 | ||||
| Series B | Aug 6, 2015 |
Antiva Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sirona Capital | Series C Extension, Series D |
| Brace Pharma Capital | Series C, Series C Extension, Series D |
| GV | Series E, Series D |
| Hillhouse Investment | Series C Extension |
| Gaingels | Series D |
| Mana Ventures | Series D |
| Avestria Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 530% MoM, reaching 1.8K.
Antiva Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Antiva Biosciences's valuation, stock price, and market status.
